The Healthcare CEO’s Guide to Negotiating Rollover Equity Like a Pro
The Healthcare CEO’s Guide to Negotiating Rollover Equity Like a Pro Key Takeaways Rollover Equity 101: The Real Trade Rollover equity means reinvesting part of your sale proceeds into the new platform so your interests align with the buyer’s growth plan. In healthcare, this shows up often in PE, MSO, and DSO-style deals. The practical […]
Read More
How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3)
How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3) Key Takeaways Why “Legacy vs. Price” Is a False Tradeoff in 2026 Healthcare M&A Buyers don’t only purchase EBITDA—they underwrite risk, retention, and continuity. If your brand, clinicians, and patient experience are fragile, the price gets discounted. If they’re durable, multiples rise. […]
Read More